Wedge Industrial (000534) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
9 Jul, 2026Executive summary
Revenue for Q1 2025 reached ¥335.04 million, up 15.34% year-over-year.
Net profit attributable to shareholders was ¥72.69 million, a 10.52% increase year-over-year.
Basic EPS rose to ¥0.1457, up 10.63% from the same period last year.
Financial highlights
Operating cash flow was negative at -¥24.01 million, down 43.99% year-over-year.
Total assets at quarter-end were ¥4.08 billion, up 2.79% from year-end 2024.
Shareholders’ equity increased 9.62% to ¥1.49 billion compared to year-end 2024.
Non-recurring profit items contributed ¥3.60 million, mainly from government subsidies.
Outlook and guidance
High-temperature alloy revenue grew 63.80% year-over-year, driving cost structure changes.
R&D expenses surged 121.34% due to increased investment in subsidiaries.
Latest events from Wedge Industrial
- Net profit rose 12.49% YoY on higher revenue and robust pharmaceutical segment growth.000534
Q2 20249 Jul 2026 - Q3 2024 saw double-digit profit growth, robust cash flow, and major investments in expansion.000534
Q3 20249 Jul 2026 - Audit confirms accurate related party fund flows and significant intra-group transactions in 2024.000534
Q4 20249 Jul 2026 - Revenue and profit surged, with robust growth in pharma and alloy businesses and strategic investments.000534
Q2 20259 Jul 2026 - Revenue and profit surged over 20% year-over-year, led by high-temperature alloy sales.000534
Q3 20259 Jul 2026 - Revenue up 19.62% to ¥1.29B, net profit up 2.22%, with strong R&D and no cash dividend.000534
Q4 20259 Jul 2026 - Q1 2026 saw revenue and profit growth, negative cash flow, and major strategic investment in a subsidiary.000534
Q1 20269 Jul 2026